Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cytosorbents (CTSO) Gains from Sales and Divestitures (2019 - 2025)

Cytosorbents' Gains from Sales and Divestitures history spans 7 years, with the latest figure at $65000.0 for Q4 2025.

  • Quarterly results put Gains from Sales and Divestitures at $65000.0 for Q4 2025, up 62.5% from a year ago — trailing twelve months through Dec 2025 was $65000.0 (up 62.5% YoY), and the annual figure for FY2025 was $65000.0, up 62.5%.
  • Gains from Sales and Divestitures for Q4 2025 was $65000.0 at Cytosorbents, up from $35000.0 in the prior quarter.
  • In the past five years, Gains from Sales and Divestitures ranged from a high of $297169.0 in Q3 2024 to a low of $20000.0 in Q2 2024.
  • The 5-year median for Gains from Sales and Divestitures is $63750.0 (2023), against an average of $99601.2.
  • Peak annual rise in Gains from Sales and Divestitures hit 595.0% in 2025, while the deepest fall reached 88.22% in 2025.
  • Year by year, Gains from Sales and Divestitures stood at $196525.0 in 2021, then tumbled by 77.1% to $45000.0 in 2022, then soared by 38.89% to $62500.0 in 2023, then plummeted by 36.0% to $40000.0 in 2024, then surged by 62.5% to $65000.0 in 2025.
  • According to Business Quant data, Gains from Sales and Divestitures over the past three periods came in at $65000.0, $35000.0, and $139000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.